Nahdi Medical Company

Saudi Stock Exchange 4164.SR

Nahdi Medical Company Dividend Yield on January 14, 2025: 4.61%

Nahdi Medical Company Dividend Yield is 4.61% on January 14, 2025, a 20.05% change year over year. Dividend yield measures the dividend per share relative to stock's price value; higher yield suggests higher dividend return.

Nahdi Medical Company 52-week high Dividend Yield is 4.76% on November 27, 2024, which is 3.34% above the current Dividend Yield.
Nahdi Medical Company 52-week low Dividend Yield is 3.59% on March 26, 2024, which is -22.16% below the current Dividend Yield.
Nahdi Medical Company average Dividend Yield for the last 52 weeks is 4.19%.

Key data

Date	Dividend Yield	Free Cash Flow Yield	Earnings Yield	Enterprise Value (EV)

Saudi Stock Exchange: 4164.SR

Nahdi Medical Company

CEO	Mr. Yasser Ghulam Bin Abdulaziz Joharji
IPO Date	April 18, 2022
Location	Saudi Arabia
Headquarters	Abraq Al-Roghamah District
Employees	5,169
Sector	Health Care
Industries Drugstores & Retail Pharmacies Pharmaceuticals

Description

Nahdi Medical Company operates as a pharmaceutical retailer in the Kingdom of Saudi Arabia and the United Arab Emirates. The company offers pharmaceutical and health products, such as medicine, wellness, mom and baby, beauty, and other FMCG products. It also provides omni-health services through its polyclinics, express clinics, telemedicine, labs, and home healthcare. In addition, the company engages in the wholesale and retail trading of cosmetics, pharmaceutical products, special and healthy foods, and medical equipment. It operates approximately 1,151 pharmacies. The company was founded in 1986 and is headquartered in Jeddah, the Kingdom of Saudi Arabia. Nahdi Medical Company operates as a subsidiary of Alnahdi Holding Company Limited and Saudi Economic and Development Company Limited.

Key trends

Past 5 years